In vitro evaluation of patch formulations for topical delivery of gentisic acid in rats

被引:18
作者
Bian, S
Doh, HJ
Zheng, JM
Kim, JS
Lee, CH
Kim, DD [1 ]
机构
[1] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea
[2] Shenyang Pharmaceut Univ, Dept Pharm, Shenyang 110015, Peoples R China
[3] Dongseo Univ, Dept Biotechnol, Pusan 617716, South Korea
基金
新加坡国家研究基金会;
关键词
gentisic acid; patches; topical delivery; formulation; permeation; skin deposition;
D O I
10.1016/S0928-0987(02)00255-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gentisic acid (GA) is used in cosmetics as a skin-whitening agent for the treatment of skin pigmentary disorders by influencing the synthesis of melanin through inhibition of melanosomal tyrosinase activity. In order to achieve effective topical delivery of GA to the active site in the skin, a matrix-type transdermal delivery system was developed. The in vitro skin permeation as well as skin deposition of GA was studied in rats. Among the five pressure-sensitive adhesives tested, DuroTak 87-2510 was the most effective to achieve the highest permeation rate of GA. Dodecylamine showed the most potent enhancement among the enhancers tested, and significantly increased the permeation rate of GA up to 112.99 (+/-30.12) mug/cm(2) per h at the concentration of 1%, when 6% GA was incorporated in DuroTak 87-2510. Moreover, a linear relationship was observed between the skin permeation rate of GA and the amount of the skin deposition after 12 h of permeation (r(2) =0.95). Thus, the in vitro skin permeation data may be useful to determine the amount of GA actually deposited in the skin. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 25 条
[1]   In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum [J].
Alberti, I ;
Kalia, YN ;
Naik, A ;
Bonny, JD ;
Guy, RH .
JOURNAL OF CONTROLLED RELEASE, 2001, 71 (03) :319-327
[2]   Enhancing effect of hydroxypropyl-β-cyclodextrin on cutaneous penetration activation of ethyl 4-biphenylyl acetate in hairless mouse skin [J].
Arima, H ;
Miyaji, T ;
Irie, T ;
Hirayama, F ;
Uekama, K .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (01) :53-59
[3]  
ARRAUDEAU J, 1998, Patent No. 5766613
[4]   CONTRIBUTIONS OF DRUG SOLUBILIZATION, PARTITIONING, BARRIER DISRUPTION, AND SOLVENT PERMEATION TO THE ENHANCEMENT OF SKIN PERMEATION OF VARIOUS COMPOUNDS WITH FATTY-ACIDS AND AMINES [J].
AUNGST, BJ ;
BLAKE, JA ;
HUSSAIN, MA .
PHARMACEUTICAL RESEARCH, 1990, 7 (07) :712-718
[5]   ENHANCEMENT OF THE DEPIGMENTING EFFECT OF HYDROQUINONE BY CYSTAMINE AND BUTHIONINE SULFOXIMINE [J].
BOLOGNIA, JL ;
SODI, SA ;
OSBER, MP ;
PAWELEK, JM .
BRITISH JOURNAL OF DERMATOLOGY, 1995, 133 (03) :349-357
[6]   KOJIC ACID, A COSMETIC SKIN WHITENING AGENT, IS A SLOW-BINDING INHIBITOR OF CATECHOLASE ACTIVITY OF TYROSINASE [J].
CABANES, J ;
CHAZARRA, S ;
GARCIACARMONA, F .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (12) :982-985
[7]   INCREASED SKIN PERMEABILITY FOR LIPOPHILIC MOLECULES [J].
COOPER, ER .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (08) :1153-1156
[8]   Inhibitors of mammalian melanocyte tyrosinase:: In vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors [J].
Curto, EV ;
Kwong, C ;
Hermersdörfer, H ;
Glatt, H ;
Santis, C ;
Virador, V ;
Hearing, VJ ;
Dooley, TP .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (06) :663-672
[9]   OLEIC-ACID - ITS EFFECTS ON STRATUM-CORNEUM IN RELATION TO (TRANS)DERMAL DRUG DELIVERY [J].
FRANCOEUR, ML ;
GOLDEN, GM ;
POTTS, RO .
PHARMACEUTICAL RESEARCH, 1990, 7 (06) :621-627
[10]   Transdermal delivery of highly lipophilic drugs:: In vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations [J].
Funke, AP ;
Schiller, R ;
Motzkus, HW ;
Günther, C ;
Müller, RH ;
Lipp, R .
PHARMACEUTICAL RESEARCH, 2002, 19 (05) :661-668